RPG Life Sciences Limited — Investor Meet, 05-05-2025: Analysts/Institutional Investor Meet/Con. Call Updates

The earnings call covered the financial results for the quarter and year ended March 31, 2025, highlighting revenue growth, margin improvement, and PAT expansion. Management emphasized strong operational execution, cost controls, and focus on key growth areas like new markets and product innovation. Order book remained healthy with steady inflows supporting near-term visibility. Analysts queried demand trends and margin sustainability; management expressed confidence in navigating challenges. The tone was positive, underscoring disciplined growth and strategic initiatives to enhance long-term value.